Above Food Ingredients Inc
ABVE
ABVE was delisted on the 1st of June, 2026.
7 hedge funds and large institutions have $38.5K invested in Above Food Ingredients Inc in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
9% more capital invested
Capital invested by funds: $35.1K → $38.5K (+$3.32K)
0.04% more ownership
Funds ownership: 0.22% → 0.26% (+0.04%)
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$6.7K |
| 2 |
VF
Virtu Financial
New York
|
+$3.35K |
| 3 |
RCM
Ravenstone Capital Management
Toronto,
|
+$504 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$28.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$98 |
ABVE Hedge Fund Activity: Q4 2024 in Review
7 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Above Food Ingredients Inc (ABVE) for Q4 2024, worth a combined $38.5K — up 9.4% from $35.1K a quarter earlier.
Fund positioning in ABVE was balanced in Q4 2024: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $6.7K. The largest seller was Goldman Sachs, exiting entirely with an estimated $28.6K sold.
- 7 institutional investors held Above Food Ingredients Inc (ABVE) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $38.5K of Above Food Ingredients Inc stock for Q4 2024, up 9.4% quarter-over-quarter.
- 2 funds opened new Above Food Ingredients Inc positions in Q4 2024 and 2 closed out, a net change of 0 holders.
- The largest Above Food Ingredients Inc buyer in Q4 2024 was HRT Financial, an estimated $6.7K added.
- The largest Above Food Ingredients Inc seller in Q4 2024 was Goldman Sachs, an estimated $28.6K sold.
Based on aggregated 13F filings for Q4 2024.